# Single Ascending Dose Trial in Patients With Type 2 Diabetes

> **NCT01492465** · PHASE1 · TERMINATED · sponsor: **Amgen** · enrollment: 47 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** AMG 876

## Key facts

- **NCT ID:** NCT01492465
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11
- **Primary completion:** 2012-07
- **Final completion:** 2012-10
- **Target enrollment:** 47 (ACTUAL)
- **Why stopped:** Decision by Sponsor
- **Last updated:** 2013-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01492465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01492465, "Single Ascending Dose Trial in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01492465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*